Ideas that have the potential to shape industries may end up stuck in the corporate basement. So how can companies embrace risky — but potentially revolutionary — ideas? Authors Safi Bahcall and Hugh Molotsi tackle this question in a main stage session at Innovation Leader’s 2019 Impact event. Bahcall also discusses learnings from his time as the CEO of Synta Pharmaceuticals, a company focused on developing new cancer treatments. Molotsi shares his experiences as a CEO of a startup and Vice President at Intuit. This session is moderated by Innovation Leader CEO Scott Kirsner.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
